
Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines
Author(s) -
K.S. Vannice,
A. Wilder-Smith,
A.D.T. Barrett,
K. Carrijo,
M. Cavaleri,
A. de Silva,
A.P. Durbin,
T. Endy,
E. Harris,
B.L. Innis,
L.C. Katzelnick,
P.G. Smith,
W. Sun,
S.J. Thomas,
J. Hombach
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/gk3w-8724
Subject(s) - dengue fever , dengue vaccine , virology , attenuated vaccine , dengue virus , medicine , biology , genetics , gene , virulence